Olivier Humbert Selected Research

Olivier Humbert Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 03/2004
11	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
4	Hemoglobinopathies 11/2021 - 03/2018
3	Infections 11/2021 - 01/2011
3	Pathologic Complete Response 01/2018 - 12/2015
3	Triple Negative Breast Neoplasms 01/2018 - 12/2015
2	Leukemia 01/2022 - 01/2019
2	Inborn Genetic Diseases (Disease, Hereditary) 11/2021 - 01/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2020
2	Vesicular Stomatitis 01/2021 - 01/2016
2	Brain Neoplasms (Brain Tumor) 01/2019 - 01/2017
2	Hodgkin Disease (Hodgkin's Disease) 01/2015 - 04/2014
2	Tuberculosis (Tuberculoses) 04/2011 - 11/2006
1	Gastritis 01/2022
1	Uveal melanoma 01/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 12/2021
1	Genetic Translocation (Chromosomal Translocation) 12/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2021
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 11/2021
1	Hypercholesterolemia 11/2021
1	Retinal Diseases 11/2021
1	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 01/2021
1	Fanconi Anemia (Fanconi's Anemia) 06/2020
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 06/2020
1	Movement Disorders (Movement Disorder) 01/2020
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2020
1	Astrocytoma (Pilocytic Astrocytoma) 01/2020
1	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2020
1	Body Weight (Weight, Body) 12/2019
1	Ductal Carcinoma 12/2019
1	Myositis (Idiopathic Inflammatory Myopathies) 12/2019
1	Sickle Cell Anemia (Hemoglobin S Disease) 03/2019
1	Thalassemia 03/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Residual Neoplasm 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	beta-Thalassemia (Cooley's Anemia) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Pheochromocytoma 10/2015

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2015
10	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 04/2012
7	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 04/2012
4	Fetal Hemoglobin (Hemoglobin F)IBA 12/2021 - 03/2018
4	Biological ProductsIBA 01/2020 - 01/2018
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
3	human ERBB2 proteinIBA 04/2019 - 03/2014
3	Phenobarbital (Luminal)FDA Link 04/2019 - 03/2014
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2011
2	Estrogen ReceptorsIBA 12/2019 - 08/2014
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2022
1	Thymidine KinaseIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	RNA Splicing FactorsIBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2021
1	Gemtuzumab (Mylotarg)FDA Link 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	DiamondIBA 06/2020
1	Death Domain ReceptorsIBA 01/2020
1	arginyl-glycyl-aspartic acidIBA 01/2020
1	Dopa DecarboxylaseIBA 01/2020
1	Dihydroxyphenylalanine (Dopa)IBA 01/2020
1	Protons (Proton)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Adenosine DeaminaseIBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 12/2019
1	Transcription Activator-Like Effector NucleasesIBA 03/2019
1	Hemoglobins (Hemoglobin)IBA 03/2019
1	polymethacrylic acid (PMAA)IBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2019
1	methacrylic acidIBA 01/2019
1	GoldIBA 01/2019
1	IodidesIBA 01/2018
1	Octreotide (Sandostatin)FDA LinkGeneric 09/2017
1	fluoromethylcholineIBA 01/2017
1	fluorocholineIBA 01/2017
1	Amino Acids FDA Link 01/2017
1	SuspensionsIBA 01/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016

Therapy/Procedure

10	Therapeutics 01/2022 - 04/2011
7	Neoadjuvant Therapy 12/2019 - 03/2014
6	Drug Therapy (Chemotherapy) 06/2020 - 04/2014
3	Immunotherapy 01/2022 - 01/2019
3	Transplantation 01/2021 - 03/2018
3	Radiotherapy 01/2020 - 01/2017
2	Segmental Mastectomy (Lumpectomy) 04/2019 - 11/2016
1	Denervation 01/2022
1	Hematopoietic Stem Cell Transplantation 12/2021
1	Proton Therapy 01/2020
1	Precision Medicine 01/2020
1	Mastectomy (Mammectomy) 04/2019
1	Aftercare (After-Treatment) 01/2019